A biopharmaceutical company focused on discovery and development of small-molecule drugs to treat genetic and rare diseases.
Editas Medicine is a genome editing company founded in 2013 that is using CRISPR technology to treat patients with genetically defined diseases.
Cancer drugs that target specific types of poly ADP-ribose polymerase